{"id":173977,"date":"2026-01-22T10:46:31","date_gmt":"2026-01-22T15:46:31","guid":{"rendered":"https:\/\/alphastreet.com\/india\/dharmaj-crop-guard-ltd-dharmaj-q2-2025-earnings-call-transcript\/"},"modified":"2026-01-22T10:46:31","modified_gmt":"2026-01-22T15:46:31","slug":"dharmaj-crop-guard-ltd-dharmaj-q2-2025-earnings-call-transcript","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/dharmaj-crop-guard-ltd-dharmaj-q2-2025-earnings-call-transcript\/","title":{"rendered":"Dharmaj Crop Guard Ltd (DHARMAJ) Q2 2025 Earnings Call Transcript"},"content":{"rendered":"

Dharmaj Crop Guard Ltd (NSE: DHARMAJ) Q2 2025 Earnings Call dated Nov. 11, 2024<\/span><\/strong><\/p>\n

Corporate Participants:<\/h2>\n

Rameshbhai Ravajibhai Talavia<\/strong> \u2014 Chairman and Managing Director<\/em><\/p>\n

Vinay Joshi<\/strong> \u2014 Chief Financial Officer<\/em><\/p>\n

Vishal Domadia<\/strong> \u2014 Chief Executive Officer<\/em><\/p>\n

Analysts:<\/h2>\n

Sayam Pokharna<\/strong> \u2014 Analyst<\/em><\/p>\n

Ankit Gupta<\/strong> \u2014 Analyst<\/em><\/p>\n

Pujan Shah<\/strong> \u2014 Analyst<\/em><\/p>\n

Dhwanil Desai<\/strong> \u2014 Analyst<\/em><\/p>\n

Smit Shah<\/strong> \u2014 Analyst<\/em><\/p>\n

Nirav Jimudia<\/strong> \u2014 Analyst<\/em><\/p>\n

Siddharth Agarwal<\/strong> \u2014 Analyst<\/em><\/p>\n

Ketan Athavale<\/strong> \u2014 Analyst<\/em><\/p>\n

Manthan<\/strong> \u2014 Analyst<\/em><\/p>\n

Presentation:<\/h2>\n

Operator<\/strong><\/p>\n

Ladies and gentlemen, good day, and welcome to the Dharmaj Crop Guard Limited Q2 and H1 FY ’25 Earnings Conference Call. [Operator Instructions] And there will be an opportunity for you to ask questions after the presentation concludes. [Operator Instructions]<\/p>\n

I now hand the conference over to Mr. Sayam Pokharna from TIL Advisors. Thank you, and over to you, sir.<\/p>\n

Sayam Pokharna<\/strong> \u2014 Analyst<\/em><\/p>\n

Thank you, Michelle. Welcome, everyone. Good afternoon and thanks for joining this Q2 and H1 FY ’25 earnings conference call of Dharmaj Crop Guard Limited. The investor updates have already been uploaded on the Stock Exchange and on the company website. To take us through today’s results, we have with us from the management team, Mr. Ramesh Talavia, Chairman and Managing Director; Mr. Jaman Talavia, Whole-Time Director; Mr. Vishal Domadia, Chief Executive Officer; Mr. Vinay Joshi, Chief Financial Officer. We will start with a brief opening remarks on the business performance from Ramesh sir, followed by opening remarks and financial performance by Vinay sir and then open the floor for the Q&A session.<\/p>\n

I would like to remind you all that anything and everything said on this call that represents any outlook for the future that can be construed as a forward-looking statement must be viewed in conjunction with the risk and uncertainties that we face. These risks and uncertainties have been mentioned in our prospectus and our follow up annual reports.<\/p>\n

At that side, I would now like to hand over the call to Mr. Talavia. Over to you, sir.<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong> \u2014 Chairman and Managing Director<\/em><\/p>\n

Good afternoon, ladies and gentlemen. Thank you for joining us today for Dharmaj’s Q2 and H1 FY ’25 earnings conference call. I’m pleased to share with you our company’s performance and key developments for the quarter and half year. Dharmaj has delivered a strong performance in Q2 ’25 following a robust Q1. Our revenue from operations registered a robust 21% growth. This growth was primarily driven by our Active Ingredients vertical, demonstrating our ability to capitalize on market opportunity in this segment.<\/p>\n

Our formulations remained relatively flat year-on-year, as we faced some headwinds on account of: First, a significant higher rainfalls in August and September across the major geographies, which disturbed the usual insecticide spraying schedule towards the end of the season, leading to slower business momentum across the country and this was contrary to original expectations of the industry at the beginning of the season, wherein a good monsoon was expected to help domestic sales. However, excess rains towards the end of season leads to lesser demand for agrochemicals in the last two months of season.<\/p>\n

Secondly, we also observed a price contractions of approximately 10% across the board in September, following promising price trends for agrochemicals from April to August. And these factors contributed to a marginal decrease in our B2B and B2C sales during quarter two. However, it’s important to note that we still achieved volume growth in formulations, however it was offset by lower realizations towards the end of quartet two.<\/p>\n

I’m pleased to report that operations at Unit 2 in Sayakha are progressing as expected, with a 12% quarter-over-quarter growth. In the first half of financial year ’25, Unit 2 has registered sales of INR1,180 [Phonetic] million. We are gradually ramping up production activities, and performance in H1 financial year ’25 has been satisfactory.<\/p>\n

Looking at the bigger picture, Dharmaj has achieved an impressive 37% top line growth in H1 ’25, with a higher contributions coming from the Active Ingredients segment. Another silver lining is that abundant rainfall across the country has led to record reservoir and water level across the country, which bodes well for a strong Rabi season. We anticipate recovering some of the momentum lost in the formulations business during the Kharif season in the upcoming Rabi season.<\/p>\n

Now, I would like to hand over to Mr. Vinay Joshi for a brief on financial performance.<\/p>\n

Vinay Joshi<\/strong> \u2014 Chief Financial Officer<\/em><\/p>\n

Hi, good afternoon, everyone. Firstly, I would like to touch upon top line growth. For Q2 we have managed a growth of 21% year-on-year, despite some impact of lower realizations. However, growth in Q2 has been more Active Ingredients driven. For H1 as whole, we have registered an impressive 37% year-on-year growth. It is important to note, while comparing growth year-on-year in FY ’25 versus FY ’24, there has been a broadbased fall in realizations from the previous half year to this. So in effect, our volume growth is in fact higher.<\/p>\n

Coming to the profitability front, our gross margins remained healthy and in line with Q1, we experienced some compression in EBITDA margins year-over-year due to a few factors, as communicated earlier in our Q4 call as well. These are higher operating expenses associated with Unit 2 operations, increased employee benefit expenses resulting from annual appraisals in July and new hirings, higher depreciation and finance costs. These factors led to a decrease in PAT on a year-over-year basis, both in Q2 and H1. However, we expect the costs associated with Unit 2 to normalize as revenues from the unit increase.<\/p>\n

Further, on the working capital front, you will notice an increase in our inventories, which is on account of operations ramp-up at Unit 2 where manufacturing lead time and inventories are higher than our formulation operations. The increase in receivables in September ’24 versus September ’23 is in line with the H1 FY ’25 versus H1 FY ’24 revenue growth.<\/p>\n

You will also see that increase in inventories has been offset by higher trade payables. Since last year, we had higher cash reserves which have now been deployed in our Unit 2, we made higher cash purchases in 2023. While this year we have limited cash purchases to very attractive deals, and made standard credit purchases, in the case of some imported raw material for Unit 2. We have also received longer credit purchases.<\/p>\n

I would also like to share that the Board has approved the incorporation of a wholly-owned subsidiary in Brazil. This is keeping in our mind our plans to grow export business in Latin America now that Unit 2 has been commissioned. The outlook for the upcoming Rabi season remains positive, supported by expectations of bumper sowing. We are making concentrated efforts to ramp-up production at Unit 2, positioning it as a key growth engine for our future expansion.<\/p>\n

Thank you for your attention. We’ll now open the floor for questions.<\/p>\n

Questions and Answers:<\/h2>\n

Operator<\/strong><\/p>\n

Thank you very much, sir. We will now begin with the question-and-answer session. [Operator Instructions] The first question is from the line of Ankit Gupta from Bamboo Capital. Please go ahead.<\/p>\n

Ankit Gupta<\/strong><\/p>\n

Yeah. Thanks for the opportunity. And my question was on both the branded as well as domestic formulations. [Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

15% [Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

Okay, okay. [Foreign Speech]<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vinay Joshi<\/strong><\/p>\n

[Foreign Speech] 30% capacity utilization will happen, but it is almost more than 50% utilization we had in this H1. So, it is above expectation. However, Rabi, the second-half we have to see because normally it is lower than H1, but now we have to see how Rabi season is going on. So, we are expecting the overall capacity utilization will be around 50% to 60% for whole year. What we are expecting as of now. And expenditure wise, if you see the fixed overhead for H1, we can see it is around INR9.5 crore other than financial and depreciation cost. So, this will be same for the next part of year also and in our earlier call…<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vinay Joshi<\/strong><\/p>\n

INR9.5 crore, which is fixed overhead for H1. It is other than finance and depreciation cost because finance and depreciation cost is around INR20 crores for Unit 2 only.<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vinay Joshi<\/strong><\/p>\n

See, gross profit it depends on certain products, it is high and it is more than 20%, but — because initially we are finding it around 20% GP for this quarter. And the major reason is the reduction in the pricing realizations.<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vinay Joshi<\/strong><\/p>\n

From EBITDA level it is around INR15 crore EBITDA level — sorry, PBT level INR15 crore losses are there.<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vinay Joshi<\/strong><\/p>\n

EBITDA level, yeah. And this year EBITDA level, we will be achieving our breakeven.<\/p>\n

Ankit Gupta<\/strong><\/p>\n

Sure.<\/p>\n

Vinay Joshi<\/strong><\/p>\n

The PBT level, we are targeting next year only once we reach the revenue of INR225 [Phonetic] crores, INR230 [Phonetic] crores.<\/p>\n

Ankit Gupta<\/strong><\/p>\n

Sure. Thank you and wish you all the best. I’ll come back in the queue.<\/p>\n

Operator<\/strong><\/p>\n

Thank you. We’ll take the next question from the line of Pujan Shah from Molecule Ventures. Please go ahead.<\/p>\n

Pujan Shah<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Pujan Shah<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Pujan Shah<\/strong><\/p>\n

Okay, sir. Thank you.<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

Okay. Thank you.<\/p>\n

Operator<\/strong><\/p>\n

The next question is from the line of Dhwanil Desai from Turtle Capital. Please go ahead.<\/p>\n

Dhwanil Desai<\/strong><\/p>\n

Good morning. [Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Dhwanil Desai<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Operator<\/strong><\/p>\n

Mr. Desai, your voice is breaking. Actually it’s a — there is a breakage when you’re talking. So can you use your handset, please?<\/p>\n

Dhwanil Desai<\/strong><\/p>\n

Just a minute, please. Is it better?<\/p>\n

Operator<\/strong><\/p>\n

Yes, much better. Thank you, sir.<\/p>\n

Dhwanil Desai<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Dhwanil Desai<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Dhwanil Desai<\/strong><\/p>\n

Okay. [Foreign Speech]<\/p>\n

Vinay Joshi<\/strong><\/p>\n

As of now, capacity utilization it is around 58% [Foreign Speech], but now we have to see what we are expecting is Rabi season is going to be good. So, we have to wait and see how Rabi season is going on and if it is better than the losses may reduce and as initially I told, but in normal scenario the breakeven will be for next year only but now we have to see the Rabi season, how it is going on, accordingly our losses will impact on the overall performance.<\/p>\n

Dhwanil Desai<\/strong><\/p>\n

Okay. [Foreign Speech]<\/p>\n

Vinay Joshi<\/strong><\/p>\n

Okay. I think your voice is breaking anyway what I understood. So, see, now this year also [Foreign Speech] we have added some two, three new products. And we are also working on to add on some few more products for next year also, which will help us in overall growth of the revenue. Regarding Brazil, it is Board has approved to incorporate a subsidiary for having a market expansion in Latin America as well and it will help us in the faster registration of our product there. So process of — we already applied for registration in Brazil, but for incorporation of company now we have to start the process and which will help us in overall revenue growth for overseas import, export as well.<\/p>\n

Dhwanil Desai<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Dhwanil Desai<\/strong><\/p>\n

Okay, sir. [Foreign Speech]<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

[Foreign Speech] after one year, next year we can start business in Brazil.<\/p>\n

Dhwanil Desai<\/strong><\/p>\n

Okay. That’s it from my side and wish you all the best. Thank you.<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

Thank you.<\/p>\n

Operator<\/strong><\/p>\n

Thank you. [Operator Instructions] The next question is from the line of Smit Shah from JHP Securities. Please go ahead.<\/p>\n

Smit Shah<\/strong><\/p>\n

Yeah. Hi, sir. [Foreign Speech]<\/p>\n

Vinay Joshi<\/strong><\/p>\n

At Peak utilization, we are targeting around INR450 crore sales in addition to the captive consumption, and that we are targeting around FY ’28 onwards.<\/p>\n

Smit Shah<\/strong><\/p>\n

Okay. But margin profile?<\/p>\n

Vinay Joshi<\/strong><\/p>\n

So, margin, once it will reach optimal utilization, then we are targeting margin of around 15% to 18%.<\/p>\n

Smit Shah<\/strong><\/p>\n

Okay, okay. Understood. [Foreign Speech]<\/p>\n

Vinay Joshi<\/strong><\/p>\n

So initial approval we got and we have submitted all the documents. So it is the [Foreign Speech]. We are hoping that by Jan, Feb we will get the final approval of the subsidy, but primary approval we’ve already received from the government.<\/p>\n

Smit Shah<\/strong><\/p>\n

Okay. [Foreign Speech]<\/p>\n

Vinay Joshi<\/strong><\/p>\n

That is on B2C segment.<\/p>\n

Smit Shah<\/strong><\/p>\n

Okay, okay. Okay, got it. Thank you so much, sir.<\/p>\n

Vinay Joshi<\/strong><\/p>\n

Thank you.<\/p>\n

Operator<\/strong><\/p>\n

Thank you. The next question is from the line of Nirav Jimudia from Anvil Corporation. Please go ahead.<\/p>\n

Nirav Jimudia<\/strong><\/p>\n

Yeah. Sir, thanks for the opportunity, Sir, I have two questions. [Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Nirav Jimudia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

Yes, yes.<\/p>\n

Nirav Jimudia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Nirav Jimudia<\/strong><\/p>\n

Got it. [Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Nirav Jimudia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Nirav Jimudia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Nirav Jimudia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Nirav Jimudia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Nirav Jimudia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Nirav Jimudia<\/strong><\/p>\n

Thank you so much, sir, and wish you all the best.<\/p>\n

Rameshbhai Ravajibhai Talavia<\/strong><\/p>\n

Thank you.<\/p>\n

Operator<\/strong><\/p>\n

[Operator Instructions] The next question is from the line of Siddharth Agarwal from Prudent Value. Please go ahead.<\/p>\n

Siddharth Agarwal<\/strong><\/p>\n

Hi, good afternoon, sir. Sir, I would like to understand [Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Siddharth Agarwal<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Siddharth Agarwal<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Siddharth Agarwal<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Siddharth Agarwal<\/strong><\/p>\n

On the ground inventory [Foreign Speech] Thank you.<\/p>\n

Vishal Domadia<\/strong><\/p>\n

Thank you.<\/p>\n

Operator<\/strong><\/p>\n

Thank you. We’ll take the next question from the line of Ketan Athavale from RoboCapital. Please go ahead.<\/p>\n

Ketan Athavale<\/strong><\/p>\n

Hello, sir. Thank you for the opportunity. [Foreign Speech]<\/p>\n

Vinay Joshi<\/strong><\/p>\n

See, this because price realization is reduced so that margin what 1% to 2%, we are expecting for this year, we may not see but of course GP margin we are seeing improvement. In EBITDA margin, we may see going forward that initial margin of 1% to 2%. And once we reach the optimal utilization in next three to four years, then we’ll see almost around 4% margin improvement.<\/p>\n

Ketan Athavale<\/strong><\/p>\n

Okay, sir. [Foreign Speech]<\/p>\n

Vinay Joshi<\/strong><\/p>\n

H1 level, more or less we will maintain at same level.<\/p>\n

Ketan Athavale<\/strong><\/p>\n

Okay. Thank you.<\/p>\n

Operator<\/strong><\/p>\n

Thank you. We’ll take the next question from the line of Manthan [Phonetic] from Alpha Wealth. Please go ahead.<\/p>\n

Manthan<\/strong><\/p>\n

Hello. Thank you for the opportunity. [Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

B2C is 25%.<\/p>\n

Manthan<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

Second one, Maharashtra [Foreign Speech]<\/p>\n

Manthan<\/strong><\/p>\n

[Foreign Speech] we’ll have a substantial revenue?<\/p>\n

Vishal Domadia<\/strong><\/p>\n

Financial year ’27. The next to next year.<\/p>\n

Manthan<\/strong><\/p>\n

Okay.<\/p>\n

Operator<\/strong><\/p>\n

Sir, do you have any further questions?<\/p>\n

Manthan<\/strong><\/p>\n

No, nothing from my side.<\/p>\n

Operator<\/strong><\/p>\n

[Operator Instructions] The next question is from the line of Ankit Gupta from Bamboo Capital. Please go ahead.<\/p>\n

Ankit Gupta<\/strong><\/p>\n

Thanks for the opportunity. [Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

Can you repeat the question?<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

Sure. [Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Ankit Gupta<\/strong><\/p>\n

Okay. Rajasthan, Maharashtra?<\/p>\n

Vishal Domadia<\/strong><\/p>\n

Maharashtra 12% and Rajasthan 9%.<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

More than 30%.<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

34%.<\/p>\n

Ankit Gupta<\/strong><\/p>\n

34%. [Foreign Speech]<\/p>\n

Vishal Domadia<\/strong><\/p>\n

[Foreign Speech] sales is only more than just double, triple.<\/p>\n

Ankit Gupta<\/strong><\/p>\n

[Foreign Speech] Thank you.<\/p>\n

Operator<\/strong><\/p>\n

Thank you. [Operator Instructions]<\/p>\n

[Operator Closing Remarks]<\/p>\n","protected":false},"excerpt":{"rendered":"

Dharmaj Crop Guard Ltd (NSE: DHARMAJ) Q2 2025 Earnings Call dated Nov. 11, 2024 Corporate Participants: Rameshbhai Ravajibhai Talavia \u2014 Chairman and Managing Director Vinay Joshi \u2014 Chief Financial Officer Vishal Domadia \u2014 Chief Executive Officer Analysts: Sayam Pokharna \u2014 Analyst Ankit Gupta \u2014 Analyst Pujan Shah \u2014 Analyst Dhwanil Desai \u2014 Analyst Smit Shah […]<\/p>\n","protected":false},"author":2377,"featured_media":147581,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[6349],"tags":[10169,9175,9104,9092,14492,10089],"class_list":["post-173977","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-transcripts","tag-earnings","tag-earnings-call","tag-earnings-conference","tag-earnings-transcripts","tag-financial-results","tag-quarterly-earnings"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":109778,"url":"https:\/\/alphastreet.com\/india\/infosys-limited-infy-q4-2021-earnings-call\/","url_meta":{"origin":173977,"position":0},"title":"Infosys Limited (INFY) Q4 2021 Earnings Call","author":"Sahil Anand","date":"April 21, 2021","format":false,"excerpt":"Infosys Limited (NYSE: INFY) Q4 2021 earnings call dated\u00a0Apr. 14, 2021 Corporate Participants: Sandeep Mahindroo\u00a0\u2014\u00a0Vice President, Financial Controller & Head \u2013 Investor Relations Salil Parekh\u00a0\u2014\u00a0Chief Executive Officer and Managing Director Pravin Rao\u00a0\u2014\u00a0Chief Operating Officer and Whole-time Director Nilanjan Roy\u00a0\u2014\u00a0Chief Financial Officer Analysts: Ankur Rudra\u00a0\u2014\u00a0JPMorgan \u2014 Analyst Diviya Nagarajan\u00a0\u2014\u00a0UBS \u2014 Analyst\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/04\/Infosys-Limited-Q4-2021-Earnings-Call.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/04\/Infosys-Limited-Q4-2021-Earnings-Call.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/04\/Infosys-Limited-Q4-2021-Earnings-Call.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/04\/Infosys-Limited-Q4-2021-Earnings-Call.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/04\/Infosys-Limited-Q4-2021-Earnings-Call.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/04\/Infosys-Limited-Q4-2021-Earnings-Call.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":41715,"url":"https:\/\/alphastreet.com\/india\/wipro-limited-wit-q2-2020-earnings-snapshot\/","url_meta":{"origin":173977,"position":1},"title":"Wipro Limited (WIT): Q2 2020 Earnings Snapshot","author":"Toby","date":"October 15, 2019","format":false,"excerpt":"-- Wipro Limited (NYSE: WIT) reported second-quarter 2020 earnings of $0.06 per share, in line with Wall Street projection -- Revenues grew 4% to $2.14 billion, vs. $2.13 billion expected. -- In Q2, IT Services revenue grew 2.5% to $2.05 billion. -- Wipro expects IT Services revenue to be $2.065\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"Earnings Update by AlphaStreet","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-Coverage-5.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-Coverage-5.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-Coverage-5.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-Coverage-5.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-Coverage-5.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":132882,"url":"https:\/\/alphastreet.com\/india\/vardhman-special-steels-limited-vssl-q1-fy23-earnings-concall-transcript\/","url_meta":{"origin":173977,"position":2},"title":"Vardhman Special Steels Limited (VSSL) Q1 FY23 Earnings Concall Transcript","author":"IRS_INDIA","date":"July 26, 2022","format":false,"excerpt":"Vardhman Special Steels Limited\u00a0(NSE:VSSL) Q1\u00a02023 Earnings Concall dated Jul. 26, 2022 Corporate Participants: Sachit Jain -- Vice-Chairman and Managing Director Sanjeev Singla -- Chief Financial Officer Analysts: Shreya Manivannan -- IIFL Securities Limited -- Analyst Umesh Gupta -- Individual Investor -- Analyst Rithwik Sheth -- One Up Finance -- Analyst\u2026","rel":"","context":"In "Earnings Call Transcripts"","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"Earnings Conference Call Transcript","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":130791,"url":"https:\/\/alphastreet.com\/india\/iol-chemicals-and-pharmaceuticals-limited-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":173977,"position":3},"title":"IOL Chemicals and Pharmaceuticals Limited Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"June 24, 2022","format":false,"excerpt":"https:\/\/youtu.be\/HCB5WuVf8_E Key highlights from IOL Chemicals and Pharmaceuticals Limited (IOLCP) Q4 FY22 Earnings Concall \u00a0 Management Update: IOLCP is optimistic on its pharma segment as capacity for other potentially large projects are ready. Gross margin in this segment is expected to improve with improved business mix. \u00a0 Q&A Highlights: Dhaval\u2026","rel":"","context":"In "Concall Highlights"","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":137767,"url":"https:\/\/alphastreet.com\/india\/natco-pharma-limited-natcopharm-q2-fy22-earnings-concall-transcript\/","url_meta":{"origin":173977,"position":4},"title":"NATCO Pharma Limited (NATCOPHARM) Q2 FY22 Earnings Concall Transcript","author":"IRS_INDIA","date":"November 11, 2022","format":false,"excerpt":"NATCO Pharma Limited (NSE:NATCOPHARM) Q2 FY22 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Rajeev Nannapaneni\u00a0--\u00a0Director and Chief Executive Officer Rajesh Chebiyam\u00a0--\u00a0Executive Vice President, Crop Health Science Analysts: Rashmi Sancheti\u00a0--\u00a0Dolat Capital -- Analyst Darshita Shah\u00a0--\u00a0Antique Brokers -- Analyst Nitin Agarwal\u00a0--\u00a0DAM Capital -- Analyst Bino Pathiparampil\u00a0--\u00a0InCred Capital -- Analyst Nikhil Upadhyay\u00a0--\u00a0SIMPL\u2026","rel":"","context":"In "Earnings Call Transcripts"","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"Earnings Conference Call Transcript","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":130734,"url":"https:\/\/alphastreet.com\/india\/clean-science-and-technology-limited-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":173977,"position":5},"title":"Clean Science and Technology Limited Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"June 21, 2022","format":false,"excerpt":"https:\/\/youtu.be\/ypPK8LiNeOc Key highlights from Clean Science and Technology Limited (CLEAN) Q4 FY22 Earnings Concall \u00a0 Management Update: All geographies and segments grew on a very healthy background. Increased new customers, increased wallet share with the existing customers, and launched some new products. Total revenue increased 34% YoverY and PBT and\u2026","rel":"","context":"In "Concall Highlights"","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/173977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/2377"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=173977"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/173977\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/147581"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=173977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=173977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=173977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}